EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex

Joseph J Maciag iD, Conner E Slone, Hala F Alnajjar, Maria F Rich, Bryce Guion, Igal Ifergan iD, Carl P Blobel iD, Tom C M Seegar iD

Proceedings of the National Academy of Sciences · 17.06.2025 · 122 (24)

DOI: 10.1073/pnas.2500732122 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 13.06.2025. Verfasst von Joseph J Maciag und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cellular Biosciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267. Hauptthemen laut MEDLINE: ADAM17 Protein, Carrier Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences (NIGMS), NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The endopeptidase activity of ADAM (a disintegrin and metalloproteinase)-17, the primary processor of several EGFR ligands and tumor necrosis factor-alpha (TNF-α), is essential for proper embryonic development and immune regulation. Dysregulated ADAM17 activity is prevalent in a wide array of human diseases, including cancer, chronic inflammation, and SARS-CoV-2 viral progression. Initially translated as an inactive zymogen, ADAM17 maturation and enzymatic function are tightly regulated by its obligate binding partners, the inactive rhomboid proteins (iRhom) -1 and -2. Here, we present the cryo-EM structure of the ADAM17 zymogen bound to iRhom2. Our findings elucidate the interactions within the ADAM17–iRhom2 complex, the inhibitory mechanisms of the therapeutic MEDI3622 antibody and ADAM17 prodomain, and the previously unknown role of a membrane-proximal cytoplasmic reentry loop of iRhom2 involved in the mechanism of activation. Importantly, we perform cellular assays to validate our structural findings and provide further insights into the functional implications of these interactions, paving the way for developing therapeutic strategies targeting this biomedically critical enzyme complex.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM17 ProteinCarrier ProteinsHumansCryoelectron MicroscopyProtein BindingSARS-CoV-2DioxygenasesModels, MolecularIntracellular Signaling Peptides and Proteins

Stichwörter der Autor:innen

ADAM17ectodomain sheddingiRhom2immunity

Substanzen

ADAM17 ProteinRHBDF2 protein, humanADAM17 protein, humanCarrier ProteinsDioxygenasesIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Molecular and Cellular Biosciences, University of Cincinnati College of Medicine, Cincinnati, OH 45267.
  • Departments of Medicine and of Biochemistry, Cell and Molecular Biology, Weill Cornell Medicine, New York, NY 10021.
  • Arthritis and Tissue Degeneration Program, Hospital for Special Surgery, New York, NY 10021.

ORCID-Profile: Joseph J Maciag, Igal Ifergan, Carl P Blobel, Tom C M Seegar

Förderung

  • NIGMS NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences (NIGMS)
  • NIH HHS

Zitieren

APA

Maciag, J. J., Slone, C. E., Alnajjar, H. F., Rich, M. F., Guion, B., Ifergan, I., Blobel, C. P., & Seegar, T. C. M. (2025). Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex. Proceedings of the National Academy of Sciences, 122(24). https://doi.org/10.1073/pnas.2500732122

Vancouver

Maciag JJ, Slone CE, Alnajjar HF, Rich MF, Guion B, Ifergan I, et al. Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex. Proceedings of the National Academy of Sciences. 2025;122(24). doi:10.1073/pnas.2500732122

BibTeX
@article{Maciag2025,
  author = {Maciag, Joseph J and Slone, Conner E and Alnajjar, Hala F and Rich, Maria F and Guion, Bryce and Ifergan, Igal and Blobel, Carl P and Seegar, Tom C M},
  title = {Structural insights into the activation and inhibition of the ADAM17–iRhom2 complex},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2025},
  volume = {122},
  number = {24},
  doi = {10.1073/pnas.2500732122}
}
Kostenlos starten →